|
KR20120048563A
|
|
Methods and compositions using peptides and proteins with c-terminal elements
|
|
US2011002897A1
|
|
Directed differentiation of stem cells
|
|
WO2010127264A2
|
|
HNF4α ANTAGONISTS AND METHODS OF USE
|
|
WO2010127246A2
|
|
Hnf4 modulators and methods of use
|
|
WO2010121207A1
|
|
Methods and compositions related to the interaction of t-cadherin and adiponectin
|
|
WO2010114921A1
|
|
Eph receptor ligands and methods of use
|
|
US2010240594A1
|
|
Targeted delivery of chemotherapeutic agents
|
|
US2010240720A1
|
|
Allosteric jnk inhibitors
|
|
WO2010075540A1
|
|
Methods and compositions for synaphically-targeted treatment for cancer
|
|
WO2010075443A1
|
|
Selective inhibitors of akt and methods of using same
|
|
WO2010044870A1
|
|
Automated scanning cytometry using chromatic aberration for multiplanar image acquisition
|
|
EP2348855A2
|
|
Small molecule compounds for stem cell differentiation
|
|
EP2334188A1
|
|
Composition and methods for the design and development of metallo-enzyme inhibitors
|
|
CA2730369A1
|
|
Compositions and methods for modulating nod-like receptor activity and uses thereof
|
|
US2010028892A1
|
|
Yeast based expression of proteases and methods of use
|
|
CA2723424A1
|
|
Intestinal alkaline phosphatase modulators and uses thereof
|
|
US2009269731A1
|
|
E3-independent ubiquitinylation assay
|
|
CA2721615A1
|
|
An inhibitor of anti-apoptotic proteins
|
|
EP2268620A2
|
|
Inhibitors of antigen receptor-induced nf- kappa b activation
|
|
US2009233993A1
|
|
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
